Roberto Vega

Dr. Roberto Vega


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2025 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
RVRoberto Vega
Roberto Vega
MDMasood Dehghan
Masood Dehghan
ANArun Nagdev
Arun Nagdev
BBBrian Buchanan
Brian Buchanan
JKJeevesh Kapur
Jeevesh Kapur
DZDornoosh Zonoobi
Dornoosh Zonoobi
Point-of-care ultrasound is a portable, low-cost imaging technology focused on answering specific clinical questions in real time. Artificial intelligence amplifies its capabilities by aiding clinicians in the acquisition and interpretation of the images; however, there are growing concerns on its effectiveness and trustworthiness. Here, we address key issues such as population bias, explainability and training of artificial intelligence in this field and propose approaches to ensure clinical effectiveness.

8 August 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
RVRoberto Vega
Roberto Vega
CKCherise Kwok
Cherise Kwok
AHAbhilash Rakkunedeth Hareendranathan
Abhilash Rakkunedeth Hareendranathan
ANArun Nagdev
Arun Nagdev
JJJacob Lester Jaremko
Jacob Lester Jaremko
This work aims to evaluate the performance of a new artificial intelligence tool (ExoAI) to compute the left ventricular ejection fraction (LVEF) in echocardiograms of the apical and parasternal long axis (PLAX) views. We retrospectively gathered echocardiograms from 441 individual patients (70% male, age: 67.3 ± 15.3, weight: 87.7 ± 25.4, BMI: 29.5 ± 7.4) and computed the ejection fraction in each echocardiogram using the ExoAI algorithm. We compared its performance against the ejection fraction from the clinical report. ExoAI achieved a root mean squared error of 7.58% in A2C, 7.45% in A4C, and 7.29% in PLAX, and correlations of 0.79, 0.75, and 0.89, respectively. As for the detection of low EF values (EF < 50%), ExoAI achieved an accuracy of 83% in A2C, 80% in A4C, and 91% in PLAX. Our results suggest that ExoAI effectively estimates the LVEF and it is an effective tool for estimating abnormal ejection fraction values (EF < 50%). Importantly, the PLAX view allows for the estimation of the ejection fraction when it is not feasible to acquire apical views (e.g., in ICU settings where it is not possible to move the patient to obtain an apical scan).